News

  • EHVA initiates a clinical trial to test a novel therapeutic vaccine and immunotherapy drug

    The European HIV Vaccine Alliance (EHVA) announces the start of the EHVA T01 / ANRS VRI05 trial, with the initiation of screening of participants at the Lausanne University Hospital Switzerland.

    Press release

europa  

This project has received funding from the European Union's Horizon 2020 research
and innovation programme under grant agreement N° 681032